Federal court judge rules in favor of Otsuka's Taiho in Lonsurf patent suit
A Delaware federal judge ruled Tuesday that the patent for Taiho Oncology’s cancer drug Lonsurf will continue to be upheld for another six years, notching …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.